# A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults

> **NCT07897708** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 98 (estimated)

## Conditions studied

- Alzheimer Disease

## Interventions

- **DRUG:** PF-08161842
- **DRUG:** Placebo for PF-08161842

## Key facts

- **NCT ID:** NCT07897708
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-11-17
- **Primary completion:** 2027-03-17
- **Final completion:** 2027-12-14
- **Target enrollment:** 98 (ESTIMATED)
- **Last updated:** 2026-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07897708

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07897708, "A Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older Adults". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07897708. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
